Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study.

Nelli, F; Fabbri, A; Onorato, A; Giannarelli, D; Silvestri, M A; Giron Berrios, J R; Virtuoso, A; Marrucci, E; Signorelli, C; Chilelli, M G; Primi, F; Schirripa, M; Mazzotta, M; Ruggeri, E M

Nelli, F; Fabbri, A; Onorato, A; Giannarelli, D; Silvestri, M A; Giron Berrios, J R; Virtuoso, A; Marrucci, E; Signorelli, C; Chilelli, M G; Primi, F; Schirripa, M; Mazzotta, M; Ruggeri, E M.

Afiliação

Nelli F; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy. Electronic address: fabrizio.nelli@asl.vt.it.
Fabbri A; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Onorato A; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Giannarelli D; Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Silvestri MA; Department of Oncology and Hematology, Microbiology and Virology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Giron Berrios JR; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Virtuoso A; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Marrucci E; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Signorelli C; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Chilelli MG; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Primi F; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Schirripa M; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Mazzotta M; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Ruggeri EM; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.

Ann Oncol ; 33(1): 107-108, 2022 01.

Article em En | MEDLINE | ID: mdl-34555502

Assuntos

COVID-19; Neoplasias; Vacina BNT162; Humanos; Neoplasias/tratamento farmacológico; Estudos Prospectivos; RNA Mensageiro; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google